- Home
- / Upstream Bio
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Upstream Bio financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$25.2
2024-10-29
Market Capitalization
$1.3 B
2024-10-29
Revenue
$2.9 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2024 | FY, 2025 |
|---|---|---|
| Revenue | 2.4M | 2.9M |
| Cost of goods sold | 6.6M | 23.0M |
| Gross profit | (4.2M) | (20.2M) |
| Gross profit margin, % | -177.6% | -706.3% |
| General and administrative expense | 17.2M | 26.4M |
| Operating expense total | 73.6M | 140.2M |
| EBIT | (77.8M) | (160.4M) |
| EBIT margin, % | -3281.2% | -5618.8% |
| Interest income | 12.1M | 16.9M |
| Interest expense | 12.1M | |
| Net Income | (62.8M) | (143.4M) |
| EPS | (5.6) | (2.7) |